11th Vaccines Research and Development: All Things Considered
EARLY BIRD DISCOUNT!
Register by May 9, 2014 to receive 20% off your registration!
2, and the 3rd goes FREE with the coupon code
Poster Submissions |
GTC is proud to present its
12th Vaccines Research & Development: All Things Considered Conference,
to be held in Boston, MA on July 9-11, 2014. This
conference continues a tradition of presenting valuable updates and exposure to
all aspects of vaccine development in a comfortable, interactive and friendly setting. It brings together
the leaders in vaccinology from industry, academia, and the government to
examine vaccine development from basic research to marketing.
together the people who make the discoveries, make the decisions, fund the work
and license the vaccines and foster their interaction with the attendees to
share their perspectives of the vaccine industry.
The 12th Vaccines Research & Development: All Things Considered
conference is part of our
Infectious Diseases World Summit 2014 and will be held concurrently with
two other tracks which are:
Influenza Research & Development
11th Anti-Infectives Partnering and Deal-Making
We look forward to seeing you in Boston!
The 2014 Advisory Committee
2014 SCIENTIFIC ADVISORY BOARD|
University of Texas
U.S. Army Medical Research Institute of Infectious Diseases
United States Agency for International Development
University of Pennsylvania
What past delegates said about the event:
"It was excellent to see Global Health as a featured tract at the GTCbio
Conference this year. The meeting was an outstanding opportunity to review many
of the most current technology platforms and product development initiatives
being used to address many of the infectious diseases that impact the developing
countries the most . It was also a welcome opportunity to spend time with many
of the industry, government and NGO stakeholders committed this important area
- Kim Bush, Director, Life Sciences Partnerships, Global Health Program, Bill &
Melinda Gates Foundation
“The GTC 11th Vaccines Research and Development: All Things Considered
conference was both an informative and highly interactive providing updates on
the latest vaccine technologies and information on the status of new or improved
- Jay t. Evans, Ph.D., Senior Scientist, GSK Vaccines.
||Attend ALL GTC Conferences for One Year
for only $3995 ($1990 for acad/govt)
here to sign up!